Hannah Fry

Insider Reports History

Entity
Individual
Location
345 Park Avenue South, 3 Rd Floor, New York, NY
Signature
/s/ Hannah Fry
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hannah Fry:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Protara Therapeutics, Inc. VP, Controller Common Stock 36.8K $175K $4.76 Jan 24, 2025 Direct
Protara Therapeutics, Inc. VP, Controller Stock Option (Right to Buy) 55K Jan 24, 2025 Direct

Insider Reports Filed by Hannah Fry

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TARA Protara Therapeutics, Inc. Jan 24, 2025 0 $0 4/A Mar 28, 2025 VP, Controller
TARA Protara Therapeutics, Inc. Jan 21, 2025 1 -$10.1K 4 Jan 23, 2025 VP, Controller
TARA Protara Therapeutics, Inc. Jan 3, 2025 1 -$2.42K 4 Jan 7, 2025 VP, Controller
TARA Protara Therapeutics, Inc. Jan 19, 2024 3 -$1.73K 4 Jan 23, 2024 VP, Controller
TARA Protara Therapeutics, Inc. Jan 3, 2024 1 -$703 4 Jan 5, 2024 VP, Controller
TARA Protara Therapeutics, Inc. Jul 17, 2023 1 -$25.8K 4 Jul 18, 2023 VP, Controller
TARA Protara Therapeutics, Inc. Jan 19, 2023 2 $0 4 Jan 20, 2023 VP, Controller
TARA Protara Therapeutics, Inc. Jan 3, 2023 1 -$1.01K 4 Jan 4, 2023 VP, Controller
TARA Protara Therapeutics, Inc. Jul 16, 2022 1 $0 4 Jul 19, 2022 VP, Controller
TARA Protara Therapeutics, Inc. Jul 16, 2022 0 $0 3 Jul 19, 2022 VP, Controller